chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 54.0
Sex: F
Vaccine: COVID19
Symptoms: Abdominal pain upper, Dizziness, Headache, Hypoaesthesia, Nausea
Clinical narrative: Fever; Nausea; Dizzy; Full body numbness; Achy; Headache; Stomach ache; This is a spontaneous report from a contactable consumer, the patient. A 54-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, lot number: ER8733) via an unspecified route of administration in the right arm on 08Apr2021 at 14:00 (at the age of 54 year-old) as a single dose for COVID-19 immunisation. Medical history included hypothyroidism. Prior to vaccination, the patient was not diagnosed with COVID-19.  The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications included levothyroxine, liothyronine (NP THYROID) from an unknown date for unknown indication and unknown if ongoing. The patient previously took local anesthesia (MANUFACTURER UNKNOWN) for unknown indication on unknown date and experienced drug allergy. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, lot number: EN6202) via an unspecified route of administration in the left arm on 11Mar2021 at 16:00 (at the age of 54-year-old) as a single dose for COVID-19 immunisation. On 09Apr2021 at 15:00, the patient experienced fever, nausea, dizzy, full body numbness, achy, headache and stomach ache. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. No therapeutic measures were taken as a result of the reported events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events fever, nausea, dizzy, full body numbness and achy were recovered with sequelae on an unknown date in 2021 while, the clinical outcome of the events headache and stomach ache were not recovered at the time of this report.
Age: 54.0
Sex: F
Vaccine: COVID19
Symptoms: Pain, Pyrexia
Clinical narrative: Fever; Nausea; Dizzy; Full body numbness; Achy; Headache; Stomach ache; This is a spontaneous report from a contactable consumer, the patient. A 54-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, lot number: ER8733) via an unspecified route of administration in the right arm on 08Apr2021 at 14:00 (at the age of 54 year-old) as a single dose for COVID-19 immunisation. Medical history included hypothyroidism. Prior to vaccination, the patient was not diagnosed with COVID-19.  The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications included levothyroxine, liothyronine (NP THYROID) from an unknown date for unknown indication and unknown if ongoing. The patient previously took local anesthesia (MANUFACTURER UNKNOWN) for unknown indication on unknown date and experienced drug allergy. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, lot number: EN6202) via an unspecified route of administration in the left arm on 11Mar2021 at 16:00 (at the age of 54-year-old) as a single dose for COVID-19 immunisation. On 09Apr2021 at 15:00, the patient experienced fever, nausea, dizzy, full body numbness, achy, headache and stomach ache. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. No therapeutic measures were taken as a result of the reported events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events fever, nausea, dizzy, full body numbness and achy were recovered with sequelae on an unknown date in 2021 while, the clinical outcome of the events headache and stomach ache were not recovered at the time of this report.
Sex: F
Vaccine: COVID19
Symptoms: Heart rate, Heart rate increased, Hypersensitivity
Clinical narrative: rapid heart rate; an allergic reaction; This is a spontaneous report from a contactable consumer (patient herself) and via Pfizer-sponsored program COVAX US Support. A female patient of an unspecified age received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection, Batch/lot number: Unknown, Expiry Date: Unknown), dose 1 via an unspecified route of administration on an unspecified date of Jan2021 as dose 1, single for COVID-19 immunisation. Medical history reported as none. There were no concomitant medications. Consumer stated that she took the Pfizer COVID-19 vaccine in January. She was experienced a rapid heart rate, immediately. The heart rate was 130 or higher. That was deemed an allergic reaction. She was then advised to not take the second dose. She was called today for more information after having had a reaction and getting the 2nd dose. She states Pfizer advised her not to take it. Also advised not to take Moderna as well. She stated that she knows there was something in the Pfizer product she may be allergic to but unsure if the ingredients are different in the "J&J" vaccine. She had an AE of a very rapid Heartbeat and was told not to take the second dose as a result; she could not take the second dose of the vaccine. Consumer stated for the reason of no lot number, she had no idea. She did not think she was going to be able to get that because she did not even know that they even gave her a vaccination card, so she was not even sure what information, she did not have that with her. On an unspecified date, the patient experienced rapid heart rate and an allergic reaction. The patient underwent lab tests and procedures which included heart rate: 130 or higher on an unspecified date. The outcome of the events was unknown.  Information on the lot/batch number has been requested.  Follow up (03Aug2021) This follow-up is being submitted to notify that the batch/lot number is not available despite the follow-up attempts made. Follow-up attempts have been completed and no further information is expected.
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity
Clinical narrative: pain in the arm; This is a spontaneous report received from a contactable consumer. A female patient of unspecified age (reporter's friend) received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection; Lot number and Expiration date: not reported) via an unspecified route of administration on an unspecified date as dose number unknown, single for COVID-19 immunisation. The patient's medical history and concomitant medications were not reported. On an unspecified date, the patient experienced pain in the arm which lasted for about a month. The reporter wanted to know if the patient was "supposed to sit in pain or get an X-ray to see what was going on with the muscle or tendon in her arm". The outcome of the reported event was unknown.  The lot number for BNT162B2 was not provided and will be requested during follow-up.
Age: 48.0
Sex: F
Vaccine: COVID19
Symptoms: Ageusia, Anosmia, SARS-CoV-2 test
Clinical narrative: Missing partial smell, no longer smell perfume; Missing partial taste, everything tastes different; This is a spontaneous report from a contactable consumer, the patient. A 48-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: En6208) via an unspecified route of administration in the left arm on 17Mar2021 at 14:00 (at the age of 48-years-old) as a single dose for COVID-19 immunisation. Medical history included hypothyroidism, neuromyelitis optica spectrum disorder (misdiagnosed NMOSD). The patient had known allergies to penicillin, keflex, ceclor, synthroid, gluten and latex. Concomitant medications included thyroid (ARMOUR THYROID) and amantadine (MANUFACTURER UNKNOWN) all from unknown dates for unknown medication and unknown if ongoing. eculizumab (SOLIRIS) for unknown indication, from unknown start date and since May2021 have stopped soliris. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: En6208) via an unspecified route of administration in the left arm on 24Feb2021 at 15:00 (at the age of 48-years-old) as a single dose for COVID-19 immunisation. Since the vaccination, the patient had been tested for COVID-19. The patient underwent lab tests and procedures, which included COVID-19 test (blood test) on 09Apr2021 and result was negative. On 21Jun2021 the patient experienced missing partial smell (she could no longer smell perfume) and taste (everything tasted different). The patient was training to be a sommelier. Loss of taste, smell did not start until june2021. The clinical outcome of the events missing partial smell (she could no longer smell perfume) and taste (everything tasted different) was not recovered at the time of this report.
Age: 69.0
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity
Clinical narrative: started sore (vaccinated arm) right after the 1st dose; This is a spontaneous report from a contactable consumer (patient) received via a Pfizer sponsored program. A 69-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection), via an unspecified route of administration, administered in arm, on an unspecified date (Batch/Lot number was unknown) (at the age of 69 years old) as dose 1, single for COVID-19 immunisation. Medical history included shaking/ shakes; allergic to hornets and yellow jackets. Concomitant medications included primidone; spironolactone. The patient started sore (vaccinated arm) right after the 1st dose on an unspecified date (reported as Tuesday). The patient reported that by the night of vaccination day, if not earlier, her arm wasn't hurting anymore. The patient recovered from the event on an unspecified date.  The lot number for BNT162B2, was not provided and will be requested during follow-up.
Sex: F
Vaccine: COVID19
Symptoms: Chest discomfort, Heart rate increased
Clinical narrative: Elevated heart rate; chest pounding following first dose.; This is a spontaneous report from a non-contactable consumer or other non-health care professional (Patient). A 45-year-old Non-pregnant female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, Lot Number: EW0176 and expiration date was not reported), first dose via an unspecified route of administration, administered in arm right on 11Jun2021 17:00 (at the age of 45 years) as single for covid-19 immunisation. Patient also received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, Lot Number: EW0176 and expiration date was not reported), second dose via an unspecified route of administration, administered in arm right on 02Jul2021 17:00 (at the age of 45 years) as single for covid-19 immunisation. Patient medical history and concomitant medications were not reported. Patient had no known allergies. Patient did not receive any other vaccines within 2 or 4 weeks prior to the COVID vaccine. Patient was not diagnosed with COVID-19, prior vaccination and since the vaccination. On 11Jun2021 18:00 the patient experienced Elevated heart rate, mild sensation of chest pounding following first dose. This persisted for the three weeks until 2nd dose and continues to date. The outcome of the events was not recovered.  Follow-up attempts are needed. No further information is Expected.
Age: 55.0
Sex: M
Vaccine: COVID19
Symptoms: Chills, Dizziness, Headache, Urticaria
Clinical narrative: really bad hives; still has some/feels a little bit, but they are not as bad; Chills; Headache; a little bit of dizziness; This is a spontaneous report from a contactable consumer (patient).   A 55-year-old male patient received BNT162B2 (PFIZER-BIOTECH COVID-19 VACCINE, solution for injection) via an unspecified route of administration, administered in arm left on 06Jul2021 16:00 (at the age of 55 years old) as dose 1, single for COVID-19 immunisation. No known medical history and concomitant medications. On 08Jul2021, the patient experienced really bad hives and still has some/feels a little bit, but they are not as bad, chills, headache, a little bit of dizziness. The patient stated that they have all improved and didn't notice these reactions until 2 days after getting the vaccine. The patient other products were reported as no. The patient history was reported as no, and the investigation assessment was reported as no. It was reported that the patient had no other vaccines given the same day or 4 weeks prior and no problems with vaccines in past. The Vaccination Facility Type was Pharmacy/Drug Store and was not administered in a military facility. The history of all previous immunization with the Pfizer vaccine considered as suspect (or patient age at first and subsequent immunizations if dates of birth or immunizations are not available) was reported as none. The Additional Vaccines Administered on Same Date of the Pfizer Suspect If applicable, list all vaccines administered on same date with the Pfizer vaccine considered as suspect was reported as none. The patient adverse events did not require a visit to the emergency room or physician office. Prior Vaccinations (within 4 weeks) If applicable, list any other vaccinations within four weeks prior to the first administration date of the suspect vaccine(s) was reported as none. There were no adverse events following prior vaccinations. The Family Medical History Relevant to adverse event and relevant tests were reported as none. The outcome of the event hives was not recovered; outcome of the events chills, headache and dizziness was recovering.   No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Sex: M
Vaccine: COVID19
Symptoms: Arthritis
Clinical narrative: have arthritis; This is a spontaneous report from a contactable consumer (patient). A male patient received second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, batch/lot number was not reported) via an unspecified route of administration on an unspecified date as single dose for COVID-19 immunization. Medical history was not reported. Concomitant medications adalimumab (Humira) daily form an unknown date. The patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, batch/lot number was not reported), via an unspecified route of administration on an unknown date as single dose for COVID-19 immunization. On an unspecified date, the patient experienced arthritis. Patient was interested in a Covid booster trial. He has had both Pfizer Covid vaccines. He adds, he does have arthritis and takes Humira daily. The patient received treatment for event. The outcome of the event was unknown.  No other additional information provided. Information on lot/batch number has been requested
Age: 56.0
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, Hypoaesthesia, Pain in extremity, Tenderness
Clinical narrative: lost strength right arm and she cannot hold up a skillet; soreness to right arm extends between elbow and wrist worsened /pain to entire right arm 24/7/she has pain from where the shot was given past her elbow to mid arm; Stated that her arm is tender to touch; numbness to right arm; This is a spontaneous report from a contactable consumer (patient). A 56-year-old female patient received second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot Number: EN5318) via an unspecified route of administration, administered in Deltoid Right on 24May2021 13:00 (age at vaccination 56-year-old) at dose 2 0.3 mL single for COVID-19 immunization. The patient medical history and concomitant medications were not reported. Patient previously took first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Lot Number: EN5318) in right deltoid on 03May2021 (age at vaccination 56-year-old) for COVID-19 immunisation and she had no side effects. Patient stated that she had her last dosage of Pfizer on 24May and had numbness to right arm on 25May2021 08:00 and soreness for a week that continued and got worst. Stated that she lost strength in her arm, cannot hold up a skillet on 28May2021 12:00, that if she lifts her arm up to reach that she has pain from where the shot was given past her elbow to mid arm on 28May2021 08:00. Stated that her arm was tender to touch and she has pain throughout her entire arm 24/7 on 28May2021 08:00. Stated that it has been going on into two months and not subsiding. Wanted to know if she was supposed to sit in pain or get an X-ray to see what was going on with the muscle or tendon in her arm. Later clarified that it was her right arm. Stated that she had no side effects from the first dose. Stated that the soreness to her right arm that has worsened to where it extends between the elbow and the wrist. Stated that her friend told her to try an anti-inflammatory. Stated that she had Ibuprofen did not work. Stated that her friends gave her balm oil, Avoniki balm, that did not work. Stated that the Motrin did not work. Stated that was about three weeks ago. Later clarified that it was Motrin and not Ibuprofen that did not work. Patient did not require a visit to emergency Room or physician Office. Prior Vaccinations (within 4 weeks) were none. The outcome of the events was not recovered.  Follow-Up (03Aug2021): Follow-up attempts are completed. No further information is expected.
Sex: M
Vaccine: COVID19
Symptoms: Limb discomfort, Peripheral swelling, Vaccination site discomfort, Vaccination site pain
Clinical narrative: Discomfort in his arm at injection site; arm was swelling; discomfort in his arm; His arm was sore, where he got injected was sore.; This is a spontaneous report from a contactable consumer. This consumer reported for two patients. This is the 2nd of two reports (father). A male patient of an unspecified age received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection), via an unspecified route of administration on an unspecified date (Batch/Lot number was not reported) as dose number unknown, single for COVID-19 immunisation. The patient's medical history and concomitant medications were not reported. The patient experienced discomfort in his arm at injection site; arm was swelling; discomfort in his arm; his arm was sore, where he got injected was sore; on an unspecified date. The outcome of events was unknown.  The lot number for BNT162B2 was not provided and will be requested during follow up.
Sex: M
Vaccine: COVID19
Symptoms: Abdominal pain upper, Dyspepsia, Headache, Pyrexia
Clinical narrative: Head was hurting; fever; stomach really hurts; heartburn; This is a spontaneous report from a non-contactable consumer. A male patient of an unspecified age received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection; Batch/Lot Number and expiration date were not reported), via an unspecified route of administration on an unspecified date (reported as on the 15th) as dose 2, single for COVID-19 immunisation. The patient's medical history and concomitant medications were not reported. The patient experienced head was hurting on an unspecified date. The patient took paracetamol (TYLENOL) as treatment for the event head was hurting. On an unspecified date, after taking Tylenol, the patient experienced fever, stomach really hurts and heartburn. The outcome of the events was unknown.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Age: 46.0
Sex: F
Vaccine: COVID19
Symptoms: Dysgeusia, Pain in extremity, Urine odour abnormal
Clinical narrative: Metallic taste in mouth; constant urine smell; arm soreness; This is a spontaneous report from a contactable consumer, the patient. A 46-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: FA6780) via an unspecified route of administration in the right arm on 17Jul2021 at 15:00 (at the age of 46-years-old) as a single dose for COVID-19 immunisation. Medical history included fibromyalgia and allergy to latex and coffee. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. Concomitant medications were not reported. The patient previously took lidocaine hydrochloride (LIDOCAINE), benzocaine (MANUFACTURER UNKNOWN) and experienced drug allergy. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0198) via an unspecified route of administration in the right arm on an unknown date in 2021 as a single dose for COVID-19 immunisation. On 17Jul2021 at 16:00, the patient experienced metallic taste in mouth, constant urine smell and arm soreness. The adverse event did not result in doctor or other healthcare professional office/clinic visit and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events metallic taste in mouth, constant urine smell and arm soreness was not resolved at the time of this report.
Age: 60.0
Sex: F
Vaccine: COVID19
Symptoms: Anxiety, Blood pressure increased, Dyspnoea, Migraine, Pain
Clinical narrative: Shortness of breath; migraine headache; caused extremely high blood pressure; elevated veins in hands and arms; swollen hands; pain in body and legs; pain in body and legs; also extreme anxiety due to side effects; This is a spontaneous report from a contactable consumer (patient).   A non-pregnant 60-year-old female patient received BNT162B2 (PFIZER-BIOTECH COVID-19 VACCINE, solution for injection), via an unspecified route of administration, administered in arm left on Jun2021 14:30 (at the age of 60 years old) as dose 1, single for COVID-19 immunisation. Medical history included none, and concomitant medications were not reported. The patient had no known allergies. The patient also received BNT162B2 (PFIZER-BIOTECH COVID-19 VACCINE, solution for injection), via an unspecified route of administration, administered in arm left on Jul2021 15:00 as dose 2, single for COVID-19 immunisation. On Jun2021, the patient experienced shortness of breath, migraine headache, caused extremely high blood pressure, elevated veins in hands and arms, swollen hands, pain in body and legs, extreme anxiety due to side effects. Symptoms became worst after the second vaccine dose. It was reported that the patient does not have high blood pressure, except resulting from vaccine side effects. The facility type vaccine was reported as pharmacy or drug store. The reported adverse event start date was Jun2021. The adverse event resulted in Doctor or other healthcare, professional office/clinic visit, Emergency room/department or urgent care. The patient had no COVID prior vaccination and did not test for COVID post vaccination. The patient was recovering from the events.   No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Age: 60.0
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity, Peripheral swelling, Peripheral vascular disorder
Clinical narrative: Shortness of breath; migraine headache; caused extremely high blood pressure; elevated veins in hands and arms; swollen hands; pain in body and legs; pain in body and legs; also extreme anxiety due to side effects; This is a spontaneous report from a contactable consumer (patient).   A non-pregnant 60-year-old female patient received BNT162B2 (PFIZER-BIOTECH COVID-19 VACCINE, solution for injection), via an unspecified route of administration, administered in arm left on Jun2021 14:30 (at the age of 60 years old) as dose 1, single for COVID-19 immunisation. Medical history included none, and concomitant medications were not reported. The patient had no known allergies. The patient also received BNT162B2 (PFIZER-BIOTECH COVID-19 VACCINE, solution for injection), via an unspecified route of administration, administered in arm left on Jul2021 15:00 as dose 2, single for COVID-19 immunisation. On Jun2021, the patient experienced shortness of breath, migraine headache, caused extremely high blood pressure, elevated veins in hands and arms, swollen hands, pain in body and legs, extreme anxiety due to side effects. Symptoms became worst after the second vaccine dose. It was reported that the patient does not have high blood pressure, except resulting from vaccine side effects. The facility type vaccine was reported as pharmacy or drug store. The reported adverse event start date was Jun2021. The adverse event resulted in Doctor or other healthcare, professional office/clinic visit, Emergency room/department or urgent care. The patient had no COVID prior vaccination and did not test for COVID post vaccination. The patient was recovering from the events.   No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Sex: M
Vaccine: COVID19
Symptoms: Pain in extremity
Clinical narrative: sore arm; This is a spontaneous report from a Pfizer-sponsored program. A contactable consumer reported (patient wife) for a male patient (husband). A 73-years old male patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, Batch/Lot number was not reported), via an unspecified route of administration on an unspecified date as DOSE NUMBER UNKNOWN, SINGLE for covid-19 immunisation. The patient medical history and concomitant medications were not reported. On an unspecified date caller reported that she and her husband had both doses of the Pfizer BCOVID19 vaccine and he had only experienced sore arm as side effect of the vaccine. The clinical outcome of event was unknown.    Information about lot/batch number has been requested.
Age: 49.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Flatulence, SARS-CoV-2 test
Clinical narrative: Really tired; stomach bubbling; This is a spontaneous report from a contactable consumer (patient) via COVAES. A 49-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection), via an unspecified route of administration, administered in right arm, on 10Apr2021 at 01:15 PM (Batch/Lot number was unknown) (at the age of 49 years old) as dose 2, single for COVID-19 immunisation. Medical history included chronic pelvic pain and other unspecified medical conditions. The patient has no known allergies. The patient was taking unspecified medications within 2 weeks of vaccination. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient was really tired and experienced stomach bubbling on 29May2021. The events resulted to physician office visit. The patient did not receive treatment for the events. The patient underwent lab tests and procedures on 20Apr2020 which included a negative nasal swab result. The patient did not recover from the events on the time of the report.  The lot number for BNT162B2 was not provided and will be requested during follow-up.
Sex: M
Vaccine: COVID19
Symptoms: Herpes zoster
Clinical narrative: onset shingles within 5 days of first dose of vaccine; This is a spontaneous report from a non-contactable consumer (patient). A 53-year-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot number: Unknown), via an unspecified route of administration on an unspecified date, as dose 1, single for COVID-19 immunisation at workplace clinic. The patient's medical history was not reported. Concomitant medications within 2 weeks of vaccination was reported as unknown. Patient did not receive other vaccine within 4 weeks of COVID vaccine. On an unspecified date, the patient experienced an onset of shingles within 5 days of first dose of vaccine. Adverse event resulted in doctor or other healthcare professional office/clinic visit. It was unknown if treatment was received for the event. The patient had no COVID prior vaccination and unknown if patient tested COVID post vaccination. The clinical outcome of the event was unknown.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Sex: F
Vaccine: COVID19
Symptoms: Therapeutic response unexpected
Clinical narrative: caused her back problems to go away.; This is a spontaneous report from a non-contactable consumer (patient) via a Pfizer-sponsored program.  A female patient of an unspecified age received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection) via an unspecified route of administration on an unspecified date (Batch/Lot number was not reported) as dose 1, single; and dose 2 via an unspecified route of administration on an unspecified date (Batch/Lot number was not reported) as dose 2, single for COVID-19 immunisation.  The patient's medical history and concomitant medications were not reported.  On an unspecified date, the patient experienced after receiving both of her doses all her symptoms have gone away (also reported she wanted to know what was in the vaccine that might have caused her back problems go away). The outcome of the event was unknown.   No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Age: 66.0
Sex: M
Vaccine: COVID19
Symptoms: Bedridden, Gait disturbance, Myalgia, Pain
Clinical narrative: Caller reported that she thinks the side effect is affecting all of the patient's muscles, sometimes he can't get off the bed and can't walk; Caller reported that the patient has such pain and they thought it would go away by now; Caller reported that she thinks the side effect is affecting all of the patient's muscles, sometimes he can't get off the bed and can't walk; Muscle ache; This is a spontaneous report from a contactable consumer (reported for her husband). A 66-years-old male patient received first dose ofBNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, solution for injection, Batch/Lot Number: EN0180, Expiration date: UNKNOWN), dose 1 via an unspecified route of administration, administered in arm right on 19Jun2021 10:00 as (At the age of 66-years) dose 1, single for COVID-19 immunization (precaution not to get the Covid). The patient's medical history included ongoing cataract, ongoing glaucoma Caller reported that the patient has had problems with cataracts and glaucoma for a very long time, probably over 10 years, eye disorder from an unknown date and unknown if ongoing patient only has 1 eye, patient eye was removed probably 20 years ago. Concomitant medications included unspecified eye drop, caller reported that the patient has been using the eye drop forever, probably over 5 years, for 6-7 years for Cataracts and glaucoma. No Investigation Assessment were reported. No Additional Vaccines Administered on Same Date of the Pfizer Suspect. It was reported that patient took his flu vaccine in 2020. The patient experienced muscle ache on 21Jun2021, patient experienced caller reported that she thinks the side effect is affecting all of the patient's muscles, sometimes he can't get off the bed and can't walk (bedridden, pain, and gait disturbance) on an unspecified date. Caller reported that the patient still has side effect of muscle aches. Caller reported that the patient has such pain and they thought it would go away by now, pain is still not going away. She thinks the side effect was affecting all of the patient muscles, sometimes he can't get off the bed and can't walk. Caller reported that the patient was afraid to get the second dose of the Covid-19 vaccine, couple days after the first dose of the Covid-19 vaccine, the patient has this pain until now. The adverse events required a visit Physician Office It was reported that the patient's physician just did some labs and said everything was fine or something like that. Caller reported that the patient went to see the doctor and they gave him Motrin and Tylenol. Patient was prescribed Motrin by his physician for muscle aches following the Covid-19 vaccine and reported that the Motrin didn't do anything and didn't work. Caller reported that she didn't know what to do with the pain that the patient was having. No emergency room visit. The outcome of event muscle ache was not recovered, and outcome of all other events was unknown.
Sex: F
Vaccine: COVID19
Symptoms: Headache
Clinical narrative: Little headache; This is a spontaneous report received from a contactable consumer (patient). A female patient of unspecified age received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection; Lot number and Expiration date: not reported) via an unspecified route of administration on an unspecified date as dose 2, single for COVID-19 immunisation. The patient's medical history and concomitant medications were not reported. On an unspecified date, after receiving the second dose, the patient experienced a little headache. The outcome of the reported event was unknown.  The lot number for BNT162B2 was not provided and will be requested during follow-up.
Sex: F
Vaccine: COVID19
Symptoms: Lymphadenopathy
Clinical narrative: lymph nodes were enlarged and still are; This is a spontaneous report from a contactable consumer (Patient). A female patient of an unspecified age received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Batch/Lot number: was not reported/ Caller unwilling to complete the report, Expiry date: Not provided) via an unspecified route of administration on 17Jul2021 as dose 1, single for COVID-19 immunization. The patient medical history was not reported. The patient's concomitant medications were not reported. On unspecified date patient lymph nodes were enlarged and still are. Additional Context: Caller just received her first dose on Saturday afternoon and by sunday afternoon her lymph nodes were enlarged and still are. She wanted to know, she has been reading different things that swollen lymph nodes aren't in the category of severe allergic reaction. Should she take the second dose vaccine or should she wait until her lymph nodes go down. Patient declined to provide- address, alternative telephone, email address. The clinical outcome of lymph node was unknown.  Information about Lot/Batch number has been requested.
Age: 45.0
Sex: F
Vaccine: COVID19
Symptoms: Axillary pain, Lymphadenopathy
Clinical narrative: Swollen lymph node under left armpit; Swollen lymph node under left armpit causing soreness; This is a spontaneous report from a contactable consumer, the patient. A 45-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0178) via an unspecified route of administration in the left arm on 18Jul2021 at 10:30 (at the age of 45-years-old) as a single dose for COVID-19 immunisation. The patients' medical history was not reported. The patient had no known allergies to medications, food or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient received unspecified medications within two weeks of the COVID-19 vaccination. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0178) via an unspecified route of administration in the left arm on 27Jun2021 at 10:30 (at the age of 45-years-old) as a single dose for COVID-19 immunisation. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccination. On 19Jul2021 at 04:00, the patient experienced swollen lymph node under left armpit which caused soreness. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care.  Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events swollen lymph node under left armpit which caused soreness was unknown at the time of this report.
Age: 66.0
Sex: F
Vaccine: COVID19
Symptoms: Body temperature, Nausea, Pain in extremity, Pyrexia
Clinical narrative: high fever of 99.9; arm pain; nausea; This is a spontaneous report from a Pfizer-sponsored program. A contactable consumer (patient) report that a 66-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection, Batch/Lot number was not reported), via an unspecified route of administration on 30Jun2021 (at the age of 66 years old) as dose 1, single for COVID-19 immunisation. The patient's medical history and concomitant medications were not reported. On 30Jun2021, the patient stated that in about five to ten minutes, she experienced a high fever of 99.9 and also had arm pain and she also experienced nausea after the first dose. She stated the arm pain and nausea came after, that the fever spiked right away and she didn't think it was 10 minutes, stated she may have had it before. The patient came in after the vaccine and it was 99.9, they gave her the vaccine, walked out and came in a little later and gave her the scan temperature to her head. She was wondering if she should get the second one. She stated that her doctor didn't really know he has other ways of dealing with the virus and she didn't know who to ask. The patient was asking how protected is she after the first dose. The outcome of the events was unknown.  The lot number for BNT162b2 was not provided and will be requested during follow up.
Age: 50.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Nausea, Pain in extremity
Clinical narrative: Headache and nausea on first dose; Headache and nausea on first dose; Thigh is painfully sore; This is a spontaneous report from a contactable consumer, the patient. A 50-year-old non-pregnant female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot Number: UNKNOWN) via an unspecified route of administration on 19Jul2021 at 17:00 (at the age of 50-years-old) as a single dose for COVID-19 immunisation. The medical history were reported as no. It was unknown whether the patient was allergic to medications, food or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The concomitant medications were not reported. On 20Jul2021 at 07:00, the patient experienced headache and nausea on first dose, thigh was painfully sore. The adverse events did not result in doctor or other healthcare professional office/clinic visit and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the reported events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events headache, nausea and thigh painfully sore was not recovered at the time of this report.    The lot number for BNT162b2 was not provided and will be requested during follow up.
Age: 31.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Fatigue, Nausea, Oropharyngeal pain, Vaccination site pruritus
Clinical narrative: Sore throatChillsNauseaTirednessInjection site itchy and swollen; chills; nausea; Tiredness; Injection site itchy; Injection site swollen; This is a spontaneous report from a non-contactable consumer, the patient. A 31-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0198) via an unspecified route of administration in the left arm on 17Jul2021(at the age of 31-years-old) as a single dose for COVID-19 immunisation. Medical history was not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. Concomitant medication was not reported. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0181) via an unspecified route of administration on an unknown date in 2021 as a single dose for COVID-19 immunisation. On 17Jul2021, the patient experienced sore throat, chills, nausea, tiredness, injection site itchy and injection site swollen. The patient did not receive any treatment for the event. The adverse event did not result in a visit to the doctors or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event sore throat, chills, nausea, tiredness, injection site itchy and injection site swollen was recovering at the time of this report.  No follow-up attempts are possible. No further information is expected.
Age: 31.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site swelling
Clinical narrative: Sore throatChillsNauseaTirednessInjection site itchy and swollen; chills; nausea; Tiredness; Injection site itchy; Injection site swollen; This is a spontaneous report from a non-contactable consumer, the patient. A 31-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0198) via an unspecified route of administration in the left arm on 17Jul2021(at the age of 31-years-old) as a single dose for COVID-19 immunisation. Medical history was not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. Concomitant medication was not reported. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0181) via an unspecified route of administration on an unknown date in 2021 as a single dose for COVID-19 immunisation. On 17Jul2021, the patient experienced sore throat, chills, nausea, tiredness, injection site itchy and injection site swollen. The patient did not receive any treatment for the event. The adverse event did not result in a visit to the doctors or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event sore throat, chills, nausea, tiredness, injection site itchy and injection site swollen was recovering at the time of this report.  No follow-up attempts are possible. No further information is expected.
Sex: F
Vaccine: COVID19
Symptoms: Pneumonitis
Clinical narrative: a friend of mine had inflammation on her lungs after receiving the 2nd Pfizer vaccine dose; This is a spontaneous report from a contactable pharmacist. A female patient of an unspecified age received Bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection), dose 2 via an unspecified route of administration on an unspecified date as dose 2, single for covid-19 immunisation. The patient medical history and concomitant medications were not reported. Historical vaccine information included bnt162b2 (COMIRNATY) 1st dose on an unknown date for COVID-19 immunisation. The patient reported that a friend of mine had inflammation on her lungs after receiving the 2nd pfizer vaccine dose on an unspecified date. It was reported that HCP states a friend of mine had inflammation on her lungs after receiving the 2nd Pfizer vaccine dose and HCP states these AEs have already been reported. The outcome for event was unknown.  Information on the lot/batch number has been requested.
Sex: M
Vaccine: COVID19
Symptoms: Body temperature, Nausea, Pyrexia
Clinical narrative: Fever 102 for 24 hours; Nausea; This is a spontaneous report from a non-contactable consumer. A male patient of 15-year-old received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration on 17Jul2021 as a single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. The patient previously took first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration on an unknown date in Jun2021 as a single dose for COVID-19 immunisation. Prior to vaccination, the patient was not diagnosed with COVID-19. It was unknown whether the patient had received any other vaccines within four weeks prior to the vaccination. On 18Jul2021, the patient experienced fever 102 for 24 hours and nausea. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of these events. On 18Jul2021, the patient underwent body temperature and the result was 102(Units unspecified). Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event fever and nausea was recovering at the time of this report.   No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Sex: U
Vaccine: COVID19
Symptoms: Alopecia
Clinical narrative: 2 people developed alopecia after getting the vaccination; This is a spontaneous report from a contactable pharmacist. A patient of unspecified age and gender received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, Batch/Lot number and expiration date was not reported), second dose via an unspecified route of administration on an unspecified date single for covid-19 immunisation. The patient medical history and concomitant medications were not reported. Patient previously bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, Batch/Lot number and expiration date was not reported), first dose via an unspecified route of administration on an unspecified date single for covid-19 immunisation. The HCP states on unspecified date of 2021 two people developed alopecia after getting the vaccination. The outcome of the event was unknown.  The lot number for the vaccine, [bnt162b2], was not provided and will be requested during follow up.
Sex: U
Vaccine: COVID19
Symptoms: Alopecia
Clinical narrative: 2 people developed alopecia after getting the vaccination; This is a spontaneous report from a contactable pharmacist.    A patient of unspecified age and gender received second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE; solution for injection; Batch/Lot number: Not reported), via an unspecified route of administration on an unspecified date as dose 2,single  for covid-19 immunization. The patient medical history and concomitant medications were not reported. The patient previously received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE; solution for injection; Batch/Lot number: Not reported), via an unspecified route of administration on an unspecified date as dose 1, single for covid-19 immunisation. It was reported that on an unspecified date the patient developed alopecia after getting the vaccination. At the time of the report the outcome of the events was unknown.  Information on the lot/batch number has been requested.
Sex: F
Vaccine: COVID19
Symptoms: Eczema
Clinical narrative: Another one of my friend 's eczema become full body eczema after her 2nd dose; This is a spontaneous report from a contactable pharmacist reported for a patient (friend). A female patient of an unspecified age received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, Batch/Lot number was not reported), via an unspecified route of administration on an unspecified date as dose 2, single for COVID-19 immunisation. Patient previously received first dose of (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, Batch/Lot number was not reported), via an unspecified route of administration on an unspecified date as dose 1, single for COVID-19 immunisation. The patient medical history and concomitant medications were not reported. The reporter reported stating "another one of my friend 's eczema become full body eczema after her 2nd dose and she had to take steroids for 2 weeks". The outcome of the event was unknown.  Follow-up attempts have been made. Information about Lot/batch number has been requested.